White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2019
Historique:
pubmed: 19 2 2019
medline: 23 7 2020
entrez: 19 2 2019
Statut: ppublish

Résumé

Higher white matter hyperintensity (WMH) load has been reported in Alzheimer's disease (AD) patients in different brain regions when compared to controls. We aimed to assess possible differences of WMH spatial distribution between AD patients and age-matched controls by means of lesion probability maps. The present study included MRI scans of 130 probable AD patients with a mean age of 73.4±8.2 years from the Prospective Dementia Registry Austria Study and 130 age-matched healthy controls (HC) from the Austrian Stroke Prevention Family Study. Risk factors such as hypertension, diabetes mellitus, hypercholesterolemia, coronary artery disease, and smoking were assessed. Manually segmented FLAIR WMH masks were non-linearly registered to a template and voxel-based probability mapping was performed. There were no significant between-group differences in cardiovascular risk factors and WMH volume. AD patients showed a significantly higher likelihood of having WMH in a bilateral periventricular distribution than controls before and after correcting for age, sex, cardiovascular risk factors, and ventricular volume (p≤0.05; threshold-free cluster enhancement corrected). There was no significant association between the periventricular WMH volume and cognitive decline of AD patients. In AD, WMH were preferentially found in a periventricular location but the volume of lesions was unrelated to cognitive decline in our study irrespective of lesion location.

Sections du résumé

BACKGROUND/OBJECTIVE
Higher white matter hyperintensity (WMH) load has been reported in Alzheimer's disease (AD) patients in different brain regions when compared to controls. We aimed to assess possible differences of WMH spatial distribution between AD patients and age-matched controls by means of lesion probability maps.
METHODS
The present study included MRI scans of 130 probable AD patients with a mean age of 73.4±8.2 years from the Prospective Dementia Registry Austria Study and 130 age-matched healthy controls (HC) from the Austrian Stroke Prevention Family Study. Risk factors such as hypertension, diabetes mellitus, hypercholesterolemia, coronary artery disease, and smoking were assessed. Manually segmented FLAIR WMH masks were non-linearly registered to a template and voxel-based probability mapping was performed.
RESULTS
There were no significant between-group differences in cardiovascular risk factors and WMH volume. AD patients showed a significantly higher likelihood of having WMH in a bilateral periventricular distribution than controls before and after correcting for age, sex, cardiovascular risk factors, and ventricular volume (p≤0.05; threshold-free cluster enhancement corrected). There was no significant association between the periventricular WMH volume and cognitive decline of AD patients.
CONCLUSION
In AD, WMH were preferentially found in a periventricular location but the volume of lesions was unrelated to cognitive decline in our study irrespective of lesion location.

Identifiants

pubmed: 30775995
pii: JAD180982
doi: 10.3233/JAD-180982
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

789-796

Subventions

Organisme : Austrian Science Fund FWF
ID : KLI 523
Pays : Austria

Auteurs

Anna Damulina (A)

Department of Neurology, Medical University of Graz, Graz, Austria.

Lukas Pirpamer (L)

Department of Neurology, Medical University of Graz, Graz, Austria.

Stephan Seiler (S)

Department of Neurology and Center for Neurosciences, Imaging of Dementia and Aging Laboratory, University of California at Davis, CA, USA.

Thomas Benke (T)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Peter Dal-Bianco (P)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Gerhard Ransmayr (G)

Department of Neurology, Kepler University Hospital, Linz, Austria.

Walter Struhal (W)

Department of Neurology, Kepler University Hospital, Linz, Austria.
Department of Neurology, Karl Landsteiner University of Health Sciences, Tulln, Austria.

Edith Hofer (E)

Department of Neurology, Medical University of Graz, Graz, Austria.

Christian Langkammer (C)

Department of Neurology, Medical University of Graz, Graz, Austria.

Marco Duering (M)

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.

Franz Fazekas (F)

Department of Neurology, Medical University of Graz, Graz, Austria.

Reinhold Schmidt (R)

Department of Neurology, Medical University of Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH